Impact and Control of Drug Therapy Guidelines for Tumor Patients During the Novel Coronavirus Pneumonia Epidemic

Abstract

Since December 2019, many unexplained viral pneumonia cases have been found in Wuhan City, Hubei Province, China. It was later confirmed that the outbreak's causative agent was a new coronavirus. The virus was temporarily named "2019-new coronavirus" (2019-nCoV) by the World Health Organization (WHO). The diseases caused by 2019-nCoV were called by the National Health and Health Commission of China "New coronavirus pneumonia" (Novel Coronavirus Pneumonia, NCP) and was named "Coronavirus disease 2019" (COVID-19) by the WHO. The outbreak of NCP seriously affected the lives of the public. This article focuses on the group of cancer patients, comprehensively considers the social, medical resources and family issues to analyze the possible impact of the epidemic on cancer patients' drug treatment and health and makes recommendations for cancer patients' management.